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Aspects of pediatric hemodynamics
Clinical estimation of hemodynamic 
status in children is very challenging.
This thesis explores and compares 
different methods for estimation 
of hemodynamic status in young 
children undergoing heart surgery.
The picture, shows part 
of the Sigurdsson family 
doing hemodynamic estimations.
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Background: Assessing critically ill patients is demanding because their clinical signs are not always easy to 
interpret. This is particularly true for pediatric patients, due to their small size and robust circulatory compensatory 
mechanism.  Physicians working in pediatric intensive care settings seldom use invasive monitoring, due to 
possible complications and the risks involved. Instead, they rely on simple vital parameters and blood gases 
during their clinical work.  However, a number of studies have shown that this clinical approach can provide 
inaccurate data when dealing with critically ill patients. There are very few monitors currently available that have 
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A less invasive hemodynamic monitor could help physicians make clinical decisions and improve future levels of 
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additional risks. 
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Results:  
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Cover image: Marey´s direct sphygmograph 
The French physiologist Étienne-Jules Marey (1830–1904) improved the 
sphygmograph in 1863 by making it portable. His instrument was the first truly non-
invasive portable device that could record the pulse wave. It included a specialized 
instrument that was placed above the radial artery and it was able to magnify pulse 
waves and record them on paper with an attached pen. 
 
(Credit: The Wellcome Collection gallery:  https://wellcomecollection.org/works  CC-
BY-4.0) 
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Introduction 
Assessing critically ill patients is demanding because their clinical signs are not always 
easy to interpret. This is particularly true for pediatric patients, due to their small size 
and robust circulatory compensatory mechanism.  Physicians working in pediatric 
intensive care settings seldom use invasive monitoring, due to possible complications 
and the risks involved. Instead, they rely on simple vital parameters and blood gases 
during their clinical work (1-2).  However, a number of studies have shown that this 
clinical approach can provide inaccurate data when dealing with critically ill patients 
(3-5). There are very few monitors currently available that have been fully validated for 
estimating hemodynamic parameters in young children (6-8).   
A less invasive hemodynamic monitor could help physicians make clinical decisions 
and improve future levels of care, by providing more reliable information on the 
perioperative hemodynamic status of pediatric patients, without additional risks (9-10). 
The aim of this thesis was to examine different aspects of pediatric hemodynamics, with 
a special focus on the novel minimally invasive, hemodynamic COstatus monitor, 
which we compared with invasive methods.  
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Background 
History of cardiac output measurements 
Since the beginning of time man has been seeking answers to different questions and 
one of those questions has been what force is responsible for life? In ancient Greece, 
Hippocrates (460 BC-370 BC), who was the father of modern medicine, was one of 
the first to state, and document, that the heart played a central role in sustaining life. 
He also identified the heart as a seat of intelligence, vitality and warmth. The Greek 
physician Claudius Galen (129-216), whose work with Roman gladiators had given 
him some fundamental understanding of how the human body worked, started 
drawing his own conclusions. He was convinced that blood was produced in the liver 
from nutrients that were extracted from the gut. The blood would then pass from the 
liver to the heart, which, in turn, would magically gain “life” and spread that life to the 
other organs of the body. Galen, whose teachings were supported by the church, had 
to restrict his research to dissecting animals, as human dissection was forbidden.   
 
Claudius Galen (129-216) the godfather of Galenic science, whose ideas dominated Europe for almost 1,400 years. 
His theories were  strongly supported by the church, as the only truth. (Picture: Wikipedia.org)  
16 
During the Islamic golden age, physician Ibn al-Nafis (1213-1288) emerged  as the 
leading scientist of the Arabic world. He made important discoveries in the fields of 
physiology and anatomy, describing pulmonary circulation in his writings and rejecting 
earlier Galenic views.  We know that translated texts of al-Nafis’ work reached Italy in 
the 15th century when traveling western physicians returned from Damascus. 
Therefore, some of his ideas on human circulation had probably been known for a 
while when the Flemish physician Andreas Vesalius (1514-1568) began his medical 
studies at the University of Padua (11).  Galenic scientific views were supported by the 
church as the only truth for more than 1400 years and anyone who dared to challenge 
those early beliefs risked being accused of heresy.  Those who went against the teaching 
of the church were labelled as scientific heretics and they included Galileo Galilei 
(1564-1642), who was accused of heresy when he dared to state that it was the earth 
that circulated around the sun. This did not discourage Vesalius, who had started 
human dissection when he realized that many of Galen’s claims about human anatomy 
were wrong (12).  The English physician William Harvey (1578-1657), who had 
followed in the footsteps of Vesalius at the University of Padua, was probably the first 
to fully understand the nature of the heart and how it was related to circulation. He 
understood that the heart worked as pump, which repeatedly drove the blood around 
the body time after time in closed circulation. As he said: “For it is by the heart's vigorous 
beat that the blood is moved”.  He published his findings in his book De Motu Cordis 
(On the Motion of the Heart) in 1628.  Harvey’s many experiments demonstrated that 
the circulation flowed in one direction and that there were two types of main vessels: 
arteries that brought the blood from the heart to the organs and veins that transported 
it back (13-14).   
    
William Harvey and illustrations from his book De Motu Cordi, published in 1628. (Illustrations: Flickr.com and 
Wikipedia.org) 
However, German physician Adolph Eugen Fick (1829-1901) was the first to realize 
how the  amount of blood being pumped from the heart could be accurately calculated 
(15).  He presented his theory in 1870 and it became known as Fick´s principle. Fick 
17 
understood that if we knew the oxygen consumption and the arteriovenous oxygen 
difference in the heart it would be easy to calculate the amount of blood the heart 
pumped each minute. He was the first to define cardiac output (CO), measured in liters 
per minute (L/min), as we know it today. However, due to Fick’s own lack of interest 
and his technical limitations, his ideas remained just that and Fick’s principle remained 
almost forgotten for 50 years.   
 
Adolf Eugen Fick (1829-1901) was an outstanding German scientist who came up with the first method of calculating 
cardiac output, know as the Fick principle. (Portrait: Wikipedia.org)  
It was not until the 1920s that the interest in measuring cardiac output was revived. 
Fick’s principle finally got the attention that it deserved when number of research 
groups in Europe and the USA started developing practical methods for measuring 
cardiac output in humans. Great progress was made in the field of cardiac physiology 
when the German physician Werner Forssman (1904-1979) inserted a urinary catheter 
into his own antecubital vein and radiographically confirmed its position in his heart.  
Forssman’s  experiment was published in his 1929 paper Über die Sondierung des 
Rechten Herzens (About Probing of the Right Heart) and the era of cardiac 
catheterization was born (16).  The following year, the Czech physician Otto Klein 
(1881-1968) drew the first mixed venous blood gas from a catheter placed in the right 
side of a human heart and calculated cardiac output for the first time, according to 
Fick’s principle (17-18).  The French physician André Frédéric Cournand (1895-1988) 
and the American physician Dickinson Richards (1895-1973), who had read 
Forssman’s and Klein´s research papers with interest, went on to experiment on 
humans and developed the standard of cardiac catheterization that we use today. In 
1956, Forssman, Cournand and Richards shared the Noble prize for medicine for their 
18 
contribution to increasing our understanding of human physiology (19). In hindsight, 
Klein should have received more credit and fame for his achievements.    
    
The pioneers of cardiac catheterization (left to right): Forssman, Cournand, Richards and Klein. (Photographs: 
Wikepedia.org and onlinejacc.org) 
In 1897 the Canadian physiologist George Neil Stewart (1860-1930) published his 
research on using a dilutional method to estimate cardiac output during a series of 
physiological experiments on animals (20). The American physiologist William 
Hamilton (1893-1964) improved Stewart´s dilutional method and was the first to use 
a dye dilutional method to measure cardiac output in humans. This became known as 
the Stewart-Hamilton principle (21). In 1948, Hamilton´s and Cournand´s research 
groups conducted a historical landmark clinical study by carrying out 48 cardiac output 
measurements in 31 patients and comparing the Fick method with the dye dilutional 
method. Their final conclusion was that both methods were interchangeable with each 
other (22).  As the Fick method was more invasive and labor-intensive, the dye 
dilutional method became the main method that was used in clinical cardiac output 
experiments. Soon after that, the first hemodynamic studies in children started to 
emerge (23-24).   
   
The pioneers of indicator dilution method, Stewart and Hamilton (from left). (Photographs: Wikepedia.org) 
19 
In 1954, the Polish physiologist George Fegler (1889-1958) suggested thermodilution 
as a possible method for measuring cardiac output, after a series of experiments in 
animals (25).  Since the invention of the Swan-Ganz pulmonary artery catheter in 
1970, which was named after its inventors Dr William Ganz and Dr Harold Swan, 
thermodilution has remained the gold standard for estimating cardiac output (26-29). 
 
Dr William Ganz (left) and Dr Harold Swan present their invention, the Swan-Ganz pulmonary artery catheter.  
(Picture: published with the permission of Peter and Tomas Ganz) 
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Reference methods for cardiac output 
estimations 
The Fick principle 
When Fick presented his theory to colleagues during a meeting in Würzburg in 1870, 
he was astonished that nobody had come up with the idea before.  As he said: “It really 
is quite simple, what comes in, must come out”. His assertion was that if we know the 
oxygen consumption, and the difference in the oxygenation of venous blood compared 
to arterial blood, we can calculate the “minute volume” of the heart, which is the amount 
of blood the heart pumps in one minute. Today we call this cardiac output. Fick used 
the following formula:  
𝐶𝑎𝑟𝑑𝑖𝑎𝑐 𝑜𝑢𝑡𝑝𝑢𝑡 = 𝑉𝑂ଶ(𝐶𝑎𝑂ଶ − 𝐶𝑣𝑂ଶ) 
where oxygen uptake ( 𝑉𝑂ଶ ) is divided by the difference in oxygen content between 
arterial and venous blood gases (𝐶𝑎𝑂ଶ − 𝐶𝑣𝑂ଶ).  
 
The Fick principle. As this model shows, if oxygen consumption is estimated to be 50 ml/min and the rise in 
oxygencontent in venous blood gas (90 ml/L) to arterial blood gas (130 ml/L) is 40 ml/L, it is easy to calculate cardiac 
output by dividing the oxygen consumption by the arteriovenous oxygen difference (50 ml/min / 40 ml/min). This 
results in a cardiac output of 1.25 L/min. (Author’s own illustration) 
22 
The Stewart-Hamilton principle 
It was obvious that when Stewart published his indicator dilutional theory in 1897 it 
was not complete.  Changes in indicator concentration were not an on/off 
phenomenon, as he suggested, but a gradual increase and decrease in concentration and 
recirculation of the indicator also had to be accounted for.  The Danish physiologist 
Valdemar Henriques (1864-1936) realized this and suggested some modifications of 
Stewart’s work, but when his results were published in a German science journal in 
1913, just before the first world war, they did not get the attention they deserved (30).  
Hamilton knew of Henriques work and made the significant modifications that were 
needed to what later became known as the Stewart-Hamilton principle (29). 
The Stewart method is based on the fact that if you inject a known amount of an 
indicator (C0V0) upstream, the change in its downstream concentration (C1) will related 
to the rate of the flow, where flow or volume over time (t) is the cardiac output (Q).   
𝑄 = 𝑉ଵ𝑡 =  
𝐶଴𝑉଴
𝐶ଵ𝑡       (Stewart method) 
The Hamilton modification simply means that cardiac output (Q) is the amount of 
indicator (C0V0) divided by the area under the curve (׬ 𝑐(𝑡)𝑑𝑡଴௧ ) 
𝑄 = ஼బ௏బ׬ ௖(௧)ௗ௧బ೟      (Hamilton modification) 
 
(Author's own illustration, example from Hamiltons original publication) 
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Transit-time flow probes 
The AU series COnfidence perivascular flow probes (Transonic Systems, Ithaca, NY, 
USA) are custom designed to fit around vessels and measure blood flow in real time by 
ultrasound transit-time technology.  Transit-time technology uses four crystals and 
wide beam illumination to send ultrasonic signals backwards and forwards across the 
vessel, alternately intersecting the blood in upstream and downstream directions. The 
flowmeter provides an accurate measurement of the transit time it takes for the 
ultrasound wave to travel from one transducer to the other. The difference between the 
upstream and downstream integrated transit times measures the volume flow, not the 
velocity.  The flow probes are available in different diameter sizes (8 to 24 mm) and 
can be used multiple times because they can undergo standard sterilization. The probes 
come ready to use and calibrated from the manufacturer, with a certified length of use 
of more than one year.  Transit-time ultrasound perivascular flow probes are considered 
to be the standard reference method for cardiac output estimation and have been 
verified by a number of studies (31-33).   
 
A perivascular flow probe. The ultrasonic measurement of blood flow in the ascending aorta provides an estimation 
of the cardiac output. However, as the probe can only be fitted to the aorta after coronaries, about 4-10% of the total 
cardiac output can be missing (Author’s own illustration, with adapted picture of flow probe with permission from 
Transonic Systems Inc).  
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Cardiac output monitors 
Over the years a number of studies have confirmed that good clinical judgement with 
regard to hemodynamic status is inaccurate in critically ill patients. This appears to be 
particularly true with pediatric patients (3, 5, 34).  Advanced hemodynamic monitoring 
remains a cornerstone of the management of critically ill patients (35-36).  The qualities 
that an ideal cardiac output monitor should have were highlighted by Shephard et al 
25 years ago [9]. Since then many cardiac output measurement monitors have been 
developed, but none of them have managed to satisfy all of Shephard et al’s criteria 
(37).  
Table 1. Shephard’s et al’s criteria for the ideal characteristics for a monitoring technique [9] 
Accurate Results obtained are a true reflection of the actual value 
Reproducible results Results obtained are comparable with those at different times in individual 
patients and from different patients 
Rapid response Rapid changes in values can be monitored 
Operator independent Results obtained from different individuals are comparable 
Easy to use The technique can be used without the need for specialized skills or training 
No morbidity No morbidity or mortality should be associated with the technique’s use 
Continuous use It should be possible to monitor variables continually, in order to distinguish 
between short-term and long-term changes 
Cheap The method should be cost-effective 
 
Invasive monitoring 
Pulmonary artery catheter (PAC) 
This specially design catheter is normally referred to as the Swan-Ganz catheter after its 
inventors. It uses thermodilution to calculate cardiac output (26-27) and can provide 
direct pressure readings from different parts of the right side of the circulation, 
including the pulmonary wedge pressure.  Validation studies have showed that the 
pulmonary artery catheter had good agreement with the dye dilution method, but even 
better precision.  As it was much easier to use in clinical practice than dye dilution, it 
became very popular in the early 1980s. However, complications occurred and its use 
26 
started to decrease in the 1990s when studies failed to show any real benefits with regard 
to mortality (38-39).  Despite its declining use in recent decades, thermodilution with 
a pulmonary artery catheter has remained the gold standard reference method of choice 
for cardiac output for the last 50 years (40).  Recent surveys in pediatric intensive care 
units in the United States and Scandinavia have shown that the pulmonary artery 
catheter is virtually never used these days in pediatric patients (2, 41). 
Transcardiopulmonary thermodilution  (TPTD) 
The Pulse index Continuous Cardiac Output, or PiCCO, (Pulsion Medical Systems, 
München, Germany) incorporates the transpulmonary thermodilution technique and 
continuous pulse contour analysis. It is an invasive monitoring technique, as clinicians 
need to insert a specific arterial catheter that has a thermistor on the end into one of 
the larger arteries, usually the femoral artery. The method provides a very 
comprehensive view of hemodynamic status.  Thermodilution enables us to estimate 
cardiac output, global end diastolic volume and extravascular lung water, while pulse 
contour analysis helps us to evaluate the fluid status by stroke volume variation (SVV).  
This information provides a better understanding of volume status and myocardial 
function, leading to optimal titration of fluids and vasoactive medication.  PiCCO has 
been validated in pediatric patients, but, because of its invasive nature, it is unclear if 
the extra hemodynamic information outweighs the technical risks that are involved (42, 
43).  
Minimally invasive monitoring 
Lithium dilution technology 
LiDCO (LiDCO Ltd, London, UK) was the first minimally invasive device to 
continuously monitor cardiac output with regular calibrations by lithium dilution, as 
it only uses existing venous and arterial catheters. The device also estimates fluid status, 
namely the pulse contour analysis of SVV, in critically ill patients. This technology 
cannot be used if the patient is already medicated with lithium or non-depolarizing 
muscle relaxants, as it can interfere with the concentration measurements.  LiDCO has 
been validated in pediatric patients, but its use has been limited, due to the use of 
lithium as the indicator and a blood loss of 3 ml during each repeated calibration (44). 
27 
Pulse contour analysis 
Advanced analytical interpretations of the arterial pulse contour waveform are emerging 
from a number of manufacturers and these provide continuous estimations of cardiac 
output and dynamic blood volumes. FloTrac (Edwards Lifescience Corporation, Irvine, 
USA) has probably become the most popular alternative in this category in recent years. 
LiDCO and PiCCO monitors have both incorporated this technology for continuous 
estimation of cardiac output, but they need to be calibrated at regular intervals. The 
advantage of this technology is that it only requires an arterial catheter, does not need 
any external calibration, is independent of the operator and is easy to use. It is based on 
the principle that there is a linear relationship between the pulse pressure and SV. The 
pressure recording analytic method (PRAM) MostCare monitor (Vytech, Padova, 
Italy) has very similar characteristics to the FloTrac technology. High-quality 
comparison studies in young children with standard reference methods are still lacking 
for both the FloTrach and PRAM monitors (45). 
Partial rebreathing method 
The Non-Invasive Cardiac Output (NICO) monitor (Novametrix Medical Systems, 
Wallingford, USA) uses a minimally invasive partial rebreathing method to determine 
cardiac output by means of a differential form of the Fick equation.  Although the name 
implies that it is non-invasive, this is not the case, as it relies on measurements and 
changes in respiratory carbon dioxide concentrations and those can only be safely 
estimated in intubated, mechanically ventilated patients. 
This approach to cardiac output estimation has been revitalized in recent years, as 
research groups have been looking into the so-called capnodynamic method and 
capnotracking method, which are based on similar principles to the NICO monitor 
(46-48).  Although these methods look promising, with regards to estimating and 
identifying trends in cardiac output, they are still being validated in animal and human 
studies. It remains to be seen if these methods will ever be reliable in pediatric patients 
(49). 
Transoesophageal Doppler (TOD) 
Placing the CardioQ Doppler ultrasound probe (Deltex Medical Ltd, Chichester, UK) 
in the upper part of the esophagus can detect blood flow in the descending aorta and 
thus estimate cardiac output (50-52).  A smaller pediatric version of this probe is 
available that provides good continuous trends of aortic blood flow. However, even a 
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very small amount of displacement can distort the readings, so there have been some 
issues regarding validation for cardiac output.  
Non-invasive monitoring 
In recent years, a number of promising non-invasive alternatives that estimate 
hemodynamic parameters have been emerging, but none of them have really met the 
standards needed to be comparable with the invasive methods (53-56). 
Echocardiography 
In the hands of a trained physician, transthoracic echocardiography can provide a good 
evaluation of the structured morphology of the heart, as well an estimation of cardiac 
output (57). The SV, which is the volume of blood the heart pumps with each 
contraction, can be calculated if we know the value of the cross section of the aortic 
valve (CSA) and multiply this by the blood flow velocity over the valve (VTI).  Finally, 
we can calculate cardiac output (CO) by multiplying the SV with the heart rate (HR).  
However, there are limitations to this method, as it is highly operator dependent and 
often very technically demanding. It can be impossible to get the echo graphic view of 
the heart needed to carry out the necessary calculations (58). A recent meta-analysis 
that compared estimates of cardiac output with echocardiography with thermodilution 
concluded that these two methods were not interchangeable (59). The SV and CO can 
be calculated using the following formulas:  
SV = CSA x VTI 
SV = stroke volume, CSA = cross-sectional area of the aorta, VTI = velocity time integral 
CO = SV x HR 
CO = cardiac output, HR = heart rate 
Electrical cardiometry 
The thoracic bioimpedance method used by the NICOM device (Cheetah Medical, 
Tel Aviv, Israel) comprises four adhesive voltage sensing and current transmitting 
electrodes, which are placed around the neck and chest to detect changes in thoracic 
bioimpedance. This makes it possible to assess stroke volume and cardiac output, as the 
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blood is ejected from the heart with every heartbeat.  Although this method has been 
approved for all patients, validation studies have shown that the accuracy and precision 
of this method is often lacking when it comes to  pediatric patients (1, 55, 60, 61). 
Studies on the bioreactance method, which is a modification of the bioimpedance 
method, have also been disappointing (62). 
Ultrasonic Cardiac Output Monitor  
The USCOM monitor (Uscom Ltd, Sydney, Australia) is a portable ultrasonic device 
that uses the Doppler principle to estimate cardiac output by detecting the aortic blood 
flow from a suprasternal position. However, there have been some reports on the 
limitations of this device, as misalignment of the probe may lead to significant errors. 
This is particularly true for children (63-66). 
Magnetic resonance imaging (MRI) 
MRI technology estimates cardiac output by using a modulus image for anatomical 
delineation of the aorta. It has been shown to be accurate and precise. Cardiac output 
can be calculated by quantifying the SV as the integral of the resulting flow curve and 
multiplying it by the HR. However, MRIs are mostly used for research, as they are time 
consuming and impractical and have no value in the daily treatment and estimation of 
critically ill patients (67-68).   
 
Overview of the technologies available for estimating cardiac output. (Author’s own illustration). 
30 
Novel technology in cardiac output measurements 
Transcardiopulmonary blood dilution ultrasound technology (TPUD) 
The COstatus (Transonic Systems Inc, Ithaca, NY, USA) is a minimally invasive 
cardiac output monitor, which detects blood dilution in an extracorporeal 
arteriovenous circuit as a saline bolus passes through the heart. This technology which 
is called “ultrasound dilution” by its manufacturer, is based on the premise that the 
ultrasound velocity of blood changes in a linear fashion with the level of blood dilution 
caused by injecting a specified bolus volume of body temperature isotonic saline. The 
ultrasound velocity in blood is 1560-1585 m/sec and decreases toward the ultrasound 
velocity of saline (1530 m/sec) after a bolus injection.  A single-use extracorporeal 
arteriovenous loop, connected between the existing arterial and central venous lines, is 
attached to an external roller pump that maintains a stable blood flow of 10-12 ml/min 
in the loop. External ultrasound sensors are then attached to specific venous and arterial 
segments of the arteriovenous loop.  The sensors measure the ultrasound velocity and 
the blood flow at the out-flow (venous) and in-flow (arterial) parts of the loop circuit.  
A measurement session begins by entering the patient’s weight, length, arterial blood 
pressure, central venous pressure and heart rate into the monitor.  The connection 
stopcock to the out-flow and in-flow segments of the AV loop, which has been primed 
with 5 ml of body temperature, heparinized isotonic saline, is opened. The roller pump 
starts and a small amount of body temperature physiological isotonic saline (0.5-1.0 
ml/kg) is injected into the out-flow segment of the loop on the venous side before the 
venous ultrasound sensor. The saline is warmed to 37 °C body temperature by a bag 
warmer that is connected to the monitor. The volume and time of the injected saline 
is determined by the venous ultrasound sensor. The saline is completely mixed as the 
blood passes through the cardiopulmonary circulation and creates homogenous blood 
dilution on the arterial side. The final blood dilution that occurs in the systemic arterial 
circulation is detected by the arterial ultrasound sensor at the arterial in-flow segment 
of the loop and an ultrasound velocity curve is generated. The technology 
simultaneously records the ultrasound velocity at a constant blood flow rate, both at 
the out-flow and in-flow segments of the loop. This means that the area under the curve 
can be analyzed. In addition, the time of occurrence, and the form of the dilution curve 
after it passes through the lungs and heart, can be used to calculate the  total end-
diastolic cardiac volume, central blood volume and active blood volume and determine 
and detect cardiac shunts. Cardiac output is calculated by analyzing the area under the 
curve, based on Stewart-Hamilton’s indicator dilution principle. 
31 
 
COstatus schematics. (Author’s own illustration). 
 
COstatus monitor display.  (Author’s own research material). 
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A number of studies have been carried out in adults and children in recent years that 
have validated, and confirmed, that transcardiopulmonary blood dilution technology 
is a promising new technology that could help physicians make clinical decisions about 
critically ill patients (69-70). 
Possible advantages of ultrasound dilution technology 
• Accurate and precise, with a rapid response 
• Innocuous, non-toxic normothermic indicator 
• Only uses existing central venous and arterial lines 
• Easy and safe to apply 
Possible limitations of ultrasound dilution technology 
• Still needs invasive catheters 
• Repeated indicator fluid boluses are needed for measurements and these can 
quickly add up  
• Continuous cardiac output readings are not yet available, but trials are ongoing 
with prototypes 
• Remains to be seen if this method is cost effective 
According to the summary above, the COstatus unit seem to fulfil at least six out of 
the eight criteria in Shephard et al’s list for the ideal cardiac output monitor (9). 
Estimation of cardiac output  (subject of Study I)  
Cardiac output can be calculated using the Stewart-Hamilton principle, as with all 
other indicator dilutional methods.  As body temperature saline is used as an indicator, 
this avoids the decrease in heart rate that is often seen when ice cold water is used with 
thermodilution methods.  It can be used to evaluate cardiac output in patients with 
intracardiac shunts, single ventricle anatomy and those receiving extracorporeal  
support (ECMO) (71). 
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Characteristic changes in the dilation curve, depending on systemic vascular resistance 
A) normal, B) vasodilation and C) vasoconstriction 
(Pictures from Shunts Modelling Program, version 1.0, Transonic Systems Inc, 2012) 
Shunt diagnosis and estimation of shunt size  (subject of Study II) 
Shunt detection is illustrated in the graphs below, which show the recirculation of the 
saline bolus. When there is a characteristic change in the dilution curve, this indicates 
that there might be an intracardiac shunt.  Studies that used the COstatus with 
pediatric patients have shown promising results with regards to diagnosing intracardiac 
shunts (69, 72). 
 
Characteristic changes in the dilution curve when an intracardiac shunt is present. 
A) no shunt, B) left to right shunt with red curve showing the shunt and C) right to left shunt with green curve 
showing the shunt.   
(Pictures from Shunts Modelling Program, version 1.0, Transonic Systems Inc, 2012) 
Normalization of hemodynamic parameters and blood volume   
(subject of Study III) 
TPUD technology is based on diluting blood and the process starts in the venous 
circulation and ends in the systemic circulation. This means that it is possible to 
estimate the blood volume status of the central circulation, namely the larger vessels 
and the heart. Transonic Systems Inc has called these novel hemodynamic variables the 
total end-diastolic volume index (TEDVI), the central blood volume index (CBVI) and 
the active circulation volume index (ACVI).  
A C B 
A B C 
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As far as we know, these hemodynamic variables have not yet been validated in clinical 
trials. 
Study III compared normalization of the hemodynamic parameters and blood volume 
with both body surface area and body weight and defined reference values for all of the 
parameters. 
 
Different blood volumes and normal reference values for the COstatus monitor device  
(Illustrations adapted from the online COstatus Monitoring information booklet by the manufacturer, Transonic 
Systems Inc). 
Total end diastolic volume (TEDV) is the blood volume in the four chambers of the 
heart at the end of diastole. It is calculated based on the assumption that a major spread 
of the arterial curve, compared to the venous curve, is due to the indicator traveling 
through the heart chambers (73).  The total end diastolic volume index (TEDVI) is the 
TEDV normalized to weight (ml/kg), as shown in the following formula: 
TEDVI = (CO *(1.62 / HR + 0.77 * CHc)) / weight 
CHc:  (CHart2 – CHven2)1/2  where CHart and CHven are the chord of the arterial and venous curves 
in minutes 
HR:  heart rate (beats per minute) 
Central blood volume (CBV) is the blood volume between the injection of the 
indicator saline bolus (central venous line) and the recording site (arterial line) and this 
includes the volume in the heart, lungs and larger central vessels.  The central blood 
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volume index (CBVI) is CBV normalized to weight (ml/kg), as shown in the following 
formula: 
CBVI = (CO * (MTTa – MTTv – MTTt) / weight) 
MTTa:  time of indicator traveling from the site of the injection (venous sensor) to the site of 
detection (arterial sensor) 
MTTv:  mean time from the venous injection until detection by the venous sensor 
MTTt:  mean indicator traveling time in the AV loop until detected by the arterial sensor 
MTTt:  Va/Qa, where Va is the priming volume in the AV loop system and Qa is the estimated 
blood flow in the AV loop 
The active circulation volume (ACV) is the blood volume that the saline indicator 
mixes in one minute from the time of the injection. It represents the volume in all the 
major organs (heart, lungs, brain, kidneys, liver) and large vessels.  The active 
circulation volume index (ACVI) is the ACV normalized to weight (ml/kg).  The ACVI 
is of special interest in infants, as it is thought to be close to the total blood volume (71) 
and this is calculated using the formula:    
ACVI = (Vinj / H) / weight 
Vinj: volume of injected isotonic saline indicator in milliliters 
H: new level of isotonic saline concentration in blood, as recorded by the arterial sensor one 
minute after the injection 
The three COstatus blood volumes, TEDV, CBV and ACV, are static parameters that 
indicate volume status, namely hypovolemic versus hypervolemic, and are all 
normalized to weight (74). Comparison studies have suggested that the COstatus 
estimates blood volumes better than thermodilution, which tends to overestimate blood 
volumes due to decreases in indicators over time, namely heat loss (75-76).   
Calorimetry for estimation of oxygen consumption (subject of Study IV) 
The direct Fick method determines cardiac output by dividing the oxygen 
consumption (mVO2) by calculating the difference between arterial (CaO2) and mixed 
venous oxygen content (CvO2). This is determined by using the Fick equation, as 
previously described:  
Q = mVO2 / (CaO2-CvO2)    (Fick equation) 
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Oxygen consumption (mVO2) is measured with indirect calorimetry. However,  there 
have been calls for greater precision and accuracy in comparison studies in recent years, 
together with growing concerns about the technical limitations and possible errors 
produced by using indirect calorimetry.  A number of studies have shown discrepancies 
between mVO2 measured by indirect calorimetry and calculated cVO2 measured by the 
reverse Fick method in adults (77-80). As the direct Fick method relies on measuring 
oxygen consumption by indirect calorimetry, measurement errors could cause false 
estimations of cardiac output. 
By using the reverse Fick method, oxygen consumption (cVO2) can be calculated if 
cardiac output (Q) has been measured by some other means and both the arterial (CaO2) 
and mixed venous blood gas (CvO2) values are known. The reverse Fick equation is 
calculated as follows: 
cVO2 = Q * (CaO2-CvO2)     (Reverse Fick equation) 
Body surface area estimations in young children  (subject of Study V) 
Since the beginning of the 20th century, body surface area has been used to normalize 
hemodynamic parameters, such as cardiac output, and this has resulted in the 
development of the cardiac index and a number of other parameters.  These have been 
produced so that clinicians can react to specific hemodynamic normal values that 
should apply to all subjects, regardless of age.  As individual body surface area 
measurements are impractical, empirical body surface formulas have been developed 
instead to estimate body surface areas.  However, a number of concerns have been raised 
in recent decades, as it has become clear to clinicians that using the body surface area 
might not be as suitable for indexing as previously thought and that estimations in 
young children were often inaccurate.  Today, there are more than 30 different body 
surface area formulas available and most of them seem to disagree with each other when 
they are used for young children.  One recent study showed that using different 
formulas to calculate body surface area estimations in children might produce 
differences of up to 50% (81).  As body surface area is often used to determine 
therapeutic doses for different treatments, such as cytotoxic anticancer drugs and 
immunosuppression therapy, this could lead to undertreatment or overtreatment of 
underlying condition and  lead to complications (82).  
The most frequently used body surface area formula today is the DuBois formula, 
which was developed by the DuBois brothers in 1916 (83-84). Most people do not 
know that this formula was only based on measurements from nine heterogenous 
subjects, including  an obese elderly female, a deformed child and an adult midget (85).  
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As this formula is used to calculate the cardiac index from cardiac output, false 
estimations of the true hemodynamic status in young children could cause a delay in 
supportive treatment in perioperative settings.  In our perfusionist protocols at Lund 
Children´s Hospital, we aim for a higher cardiac index in younger children (body 
surface area < 0.5 m2) during cardiac bypass surgery than in older subjects (2.8-3.3 
versus 2.4-2.5 L/min/m2).  If normalization with the body surface area was accurate, 
this correction would not be needed during pediatric heart surgery.  
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Validation of cardiac output monitors 
The early years (1948-1985) 
The validation of different technologies was rather limited during the early years, as 
simple correlation plots and regression analysis were used to compare different 
methods. However, they did not really provide a clear picture of how well the methods 
agreed with each other and it was soon obvious that a better way for validating different 
methods was needed. 
The Bland-Altman years (1986-1998) 
In 1986, Bland and Altman first suggested their method for comparing agreement 
between two different techniques that measured the same clinical variable (86).  Since 
then, the Bland-Altman plot and analysis has become the standard way to present 
results when a new method is being validated against an established reference technique 
(87). The Bland-Altman plot provides a clear graphical view of the results and objective 
values, namely bias, standard deviations (SDs) and limits of agreement, which make it 
easier to understand how well different techniques agree with each other. Bias gives us 
the average of all differences, SDs of the spread around the bias and limits of agreement 
±1.96 times the SD around the bias (88). Today, new cardiac output monitors should 
always be validated using the Bland-Altman method, as with all other methods and 
technologies, and the precision of the reference technology should also be known for 
comparison purposes when taking repeated measurements into account (89-93). 
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Examples of a correlation plot and a Bland-Altman plot. (Author’s own graphs). 
Modern standards (1999 to the present day) 
Even with the Bland-Altman analysis, we still didn’t have the whole picture. Something 
was missing.  We didn’t know how much difference between the techniques was 
acceptable for a new technique to be interchangeable with an established reference 
technique.  In 1999, Critchley and Critchley came up with the answer, after they 
carried out a meta-analysis on a number of cardiac output studies (94).  They suggested 
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that a percentage error of 30% should be the cut-off value, as they found that a value 
under 30% meant that both methods were comparative, but a value above 30% meant 
that they were not (95). 
A recent meta-analysis of cardiac output measurements in children highlighted a lot of 
problems and showed that an overall lack of homogeneity was an alarming concern 
(10).  Studies have claimed to conduct hemodynamic measurements in children but 
have included patients up to almost 18 years of age, often resulting in average ages 
between 8-12 years. One even included “children” under the age of 21 years. Clearly 
this is not what we are looking for when we carry out hemodynamic studies in children 
under the age of four years, for example. Very young children have a completely 
different hemodynamic profile to older children, who are almost identical to adults in 
that respect.   
It is of the utmost importance that all missing data are reported or accounted for, as it 
provides a better picture of the technique being tested. A report that comprises 50 
measurements can sound very promising in the beginning, but if you have neglected to 
mention that there were 100 measurement attempts and only 50 yielded results, you 
have not been honest about the technique’s true performance.  There often seemed to 
be missing data in many comparison studies from the early years, with five 
measurements available for comparison from some patients and just one from others.  
The reason for the inconsistent numbers of measurements were often not explained, 
which made it hard to evaluate the final results and conclusions (96). 
Power analysis for validation studies is not simple, as we often do not know what we 
are aiming for.  If we want to know how many patients we need for a study, one 
approach is to look at similar studies that have explored the same research areas.  
 
The difference between precision and accuracy. (Author’s own illustration adapted from number of previous 
publications) 
Precision tells us how close repeated measurement are to each other, while accuracy 
describes how close the measurements are to the real value. 
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Aim of the study 
The aim of the present study was to look at different aspects of hemodynamic in 
pediatric patients undergoing corrective cardiac surgery. The findings were published 
in five papers. 
Paper I investigated how well the COstatus device estimated cardiac output. It did this 
by analyzing its agreement and precision with a standard reference method, a 
perivascular flow probe placed around ascending aorta. 
Paper II compared how well the COstatus device detected intracardiac shunts, by 
comparing the results with transesophageal echocardiography. It also compared the 
estimated shunt size with two different methodological reference methods, the 
perivascular flow probe and the oximetric method. 
Paper III compared normalization of hemodynamic parameters and blood volume with 
body surface area and body weight and the effect of intracardiac shunts on the precision 
of the COstatus device. 
Paper IV compared indirect calorimetry estimates on oxygen uptake with the reverse 
Fick method. 
Paper V compared the agreement between common body surface area formulas in 
young children. 
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Methods 
Patients 
Young children undergoing elective cardiac surgery to correct an atrial septal defect 
(ASD) and/or ventricular septal defect (VSD) were enrolled in the study from June 
2014 to June 2017 if they fulfilled all the criteria. 
Inclusion criteria  
I. Informed, written parental consent (Papers I-V) 
II. Weight <15 kg (Paper I-V) 
III. ASD and/or VSD defects (Papers I-V) 
Since lack of repeatability of the cardiac output measurements could interfere with 
comparing different methods, it was important that the measurement method and the 
stroke volume were constant during the measurements. 
Exclusion criteria 
I. Shunts: undiagnosed extracardiac or significant residual shunts after surgical 
correction (Papers I and IV) 
II. Perioperative arrythmias: supraventricular, nodal tachycardia and 
atrioventricular heart blocks (Papers I -IV)   
III. Significant valvular regurgitations: aortic, mitral, tricuspid and pulmonary 
valvular leaks (Papers I-IV) 
IV. Obvious leakage despite cuffed endotracheal tube (Paper IV) 
V. Need for a high fraction of inspired oxygen during measurements (Paper IV) 
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Study design 
This study was approved and registered by the Ethics Committee of Lund University, 
Sweden. (Dnr 2013636)   
Induction of anesthesia and preparation at the beginning of each case: 
Anesthesia was induced using fentanyl (5 mcg/kg) and penthothal (5 mg/kg) and 
maintained with isoflurane (0.5-1.0%). Pancuronium (0.2 mg/kg) was given to 
facilitate intubation with a cuffed endotracheal tube. All children received a peripheral 
arterial catheter in the radial artery: Neoflow 24 G in patients <5 kg and Venflow 22 
G in patients >5 kg (both BD Ltd, Wokingham, UK). They also received a Multicath 
triple lumen 6cm, 4.5 F central venous catheter in the right internal jugular vein 
(Vygon Ltd, Swindon, UK). These catheters are routine for all cardiac surgery.  The 
catheters were then connected to a specific arteriovenous loop, which was primed with 
heparinized (2 units/mL) normothermic isotonic saline. COstatus ultrasound sensors 
were then placed on the venous and arterial side of the arteriovenous loop before the 
start of the surgery.  Cerebral and somatic tissue oxygenation was monitored with in 
vitro optical spectroscopy with the INVOS 5100C (Medtronic, Minneapolis, MN, 
USA), by placing pediatric sensors over the patient’s forehead and kidney. 
Before surgical correction: 
A preoperative transesophageal echocardiography was performed with a Philips S8-3T 
pediatric transesophageal transducer probe to determine cardiac function and existing 
defects were identified with a Philips iE33 ultrasound system (both Philips Healthcare, 
Andover, MA, USA). Conventional cross-sectional echocardiography and Doppler 
color flow were used to detect the defects. 
After exposing the heart, but before the cardiopulmonary bypass was performed, the 
surgeon consecutively placed AU series COnfidence perivascular flow probes 
(Transonic Systems, Ithaca, NY, USA) around the ascending aorta and then the 
pulmonary truncus. The size of the probes made it impossible to fit them both 
simultaneously without compromising the patient’s circulation. Five consecutive 
measurements were performed on the ascending aortic blood flow at the same time as 
five measurements with the COstatus device. This was immediately followed by five 
consecutive measurements of the pulmonary blood flow. 
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Then the surgeon took blood samples from the pulmonary truncus, inferior vena cava 
(IVC) and superior vena cava (SVC) by direct puncture. An arterial blood sample was 
simultaneously taken from the arterial catheter. The fraction of inspiratory oxygen was 
kept at 0.3–0.4 to ensure full arterial oxygen saturation and, therefore, fully saturated 
blood in the left atrium.  The pulmonary venous oxygen saturation was expected to be 
full, since the arterial oxygen saturation was 97-100%. The blood gas analyses were 
performed with the ABL800 Flex Radiometer (Radiometer AS, Brønshøj, Denmark).  
Finally, the shunt ratio was calculated using the oximetric shunt formula. The oxygen 
content in the venous blood was estimated using Flamm’s formula (3SVC+IVC)/4).  
During every measurement session the oxygen uptake (VO2) was obtained by indirect 
calorimetry using the GE Healthcare S/5 Compact Anaesthesia Monitor (Dantex 
Ohmeda Inc, Madison, WI, USA) with an E-CAiOVX module with a specific Pedi-
lite+ pediatric flow sensor adjusted to pediatric mode. 
After surgical correction 
All the measurements carried out before surgery were repeated in the same order after 
surgery, once the patient’s spontaneous circulation had returned to sinus rhythm and 
they had reached normal body temperature.  
The surgical results were controlled by a postoperative transesophageal 
echocardiography investigation, to exclude residual shunts or valvular regurgitations 
that could affect the results. This was carried out by a cardiologist who was blinded to 
the results and unaware of the other findings. 
Straight after surgery, all the data that were available on the paper prints were entered 
into a specific Windows Excel Office 365 spreadsheet (Microsoft Corporation, 
Washington, USA) to prevent any loss of critical data. These were the blood gases, 
perivascular flow probe results, COstatus estimations and oxygen uptake values.  
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Overview of the study technical setup, devices used and samples taken during measurements sessions (Author’s own 
illustration). 
Statistical analysis  
The Statistica program (Dell Inc., Tulsa, OK, USA) was used for the statistical analyses 
in all the papers. 
At the start of the study, we did not have an a priori power analysis available, as we did 
not know what bias and standard deviations to use for cardiac output so that we could 
perform the analysis.  We decided that we could use our own results and the results 
from an earlier cardiac output pilot study conducted at our hospital to calculate the 
sample size needed at a later stage in the study. During the post hoc power analysis, 
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which was carried out during the study, we estimated that 35 subjects were needed.  
We had anticipated that this would be the approximate number from our previous 
experience, and similar studies, and had originally planned to enroll around 40-50 
patients. 
This matter was addressed and presented during the revision of Paper I, but the 
statistical editor decided that our description of the power analysis did not need to be 
included in the final version of the paper (97). 
In Papers II - V we used G-Power 3.1.9.3 software (Kiel University, Kiel, Germany) 
for the power calculations, as the bias and standard deviations from previous studies on 
same parameters could be used to estimate the effect sizes and thus the number of 
subjects needed for each paper. To gain sufficient power in Papers III and V, we had 
to add extra patients from earlier cardiac output study that had been conducted with 
similar subjects (69). 
The Bland-Altman method was used to estimate the bias for all papers that compared 
different methods, SDs and limits of agreements. We took  special care with regard to 
multiple measurements in the same individual (86, 90, 98). The bias, or mean 
difference, was calculated and plotted against the average of the comparison. The 95% 
limits of agreement were calculated as the mean bias of 1.96*±SD (SD of the difference 
between the methods). The  percentage error was calculated using the equation (1.96 * 
SD bias) / (Mean Reference method) * 100% [94]. 
In Paper II we used analysis of variance to detect the statistical significance between the 
three different techniques used to determine the shunt ratios, as the values from the 
COstatus had to be categorized.  
The degree of variation for each method was estimated in both Paper I and Paper III 
by the coefficient of error (CE) of the average repeated measurements, calculated as the 
ratio of the coefficient of variation (CV) divided by the square root of the number (n) 
of repeated measurements (CE=CV/√n).  The precision of each method was then 
considered to be two times the CE, namely: (2 * CE) * 100% (89). 
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Results and discussion 
Paper I – Estimation of cardiac output 
The COstatus provided excellent precision and agreement when it came to estimating 
cardiac output in young children, compared with the gold standard of a perivascular 
flow probe placed around the ascending aorta.   
As the COstatus is less invasive than the earlier reference methods that have been 
available, and is easy and safe to use, we believe this should be considered as a possible 
new reference method for cardiac output estimations. 
Paper II – Estimation of intracardiac shunts 
COstatus detected intracardiac shunts to the same extent as the gold standard of 
echocardiography. However, it slightly underestimated the degrees of the shunts in 
small and moderate shunts when it was compared to two other reference methods, 
namely perivascular ultrasonic flow probes (placed around the pulmonary truncus and 
ascending aorta) and the oximetric shunt equation (using arterial and venous blood 
gases). 
Transonic systems algorithms for shunt calculations might be overly cautious. 
Paper III – Normalization of hemodynamic parameters 
Body weight produced a better normalization of hemodynamic parameters than body 
surface area in young children.  
The presence of an intracardiac shunt caused only a minor decrease in precision. 
Paper IV – Estimation of oxygen uptake 
Indirect calorimetry seemed to overestimate oxygen uptake in young children, 
compared to the reverse Fick method.  
Caution is advised regarding the use of the direct Fick method as a reference method 
in cardiac output comparison studies. 
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Paper V – Estimation of body surface area 
Commonly used body surface area formulas disagreed in young children.  
This could influence calculations of hemodynamic parameters that are normalized with 
body surface area and influence drug dosis based on BSA. 
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Conclusions and future directions 
Paper I  
It is important that we continue to carry out cardiac output comparison studies with 
young children.  A number of promising non-invasive cardiac output monitors are 
emerging and these need to be carefully validated in clinical settings with real pediatric 
patients. As the COstatus device is very accurate, precise and minimally invasive, it 
permits bedside measurements in pediatric patients who are awake. This will finally 
enable us to move cardiac output comparison studies from the operating theatre and 
cath lab to intensive care units. 
Paper II 
Although the COstatus can detect intracardiac shunts with high sensitivity and 
specificity, it will never replace echocardiography when it comes to diagnosing and 
evaluating intracardiac shunts. The final decision to carry out corrective surgery will 
always be based on clinical symptoms, combined with any preoperative examinations 
that are available. However, the COstatus may be particularly helpful in the 
perioperative phase, as it could detect residual intracardiac shunts missed by 
postoperative echocardiography and determine their size. At the same time it could 
provide valuable information on hemodynamic parameters and volume status. 
Paper III 
Indexing of hemodynamic parameters, such as cardiac output and blood volumes, are 
more appropriate with regard to body weight than body surface area in young children.  
This produces independent reference values for hemodynamic parameters that are more 
valid in all age groups and are more independent of body size. Static blood volumes can 
be estimated with COstatus (ACV and CBV) regardless of intracardiac shunts. This 
gives an indication of the intravascular volume status in pediatric patients, which has 
previously not been available, and this could guide fluid therapy in intensive care units.  
It remains to be seen if the next generation COstatus, which will feature a continuous 
hemodynamic display, will be able to provide pediatricians with reliable information 
on dynamic blood volumes (SVV and PPV) and estimated fluid responsiveness. 
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Paper IV 
As indirect calorimetry seems to overestimate oxygen uptake, the direct Fick method 
should not be considered a standard reference method for cardiac output comparison 
studies. It is of the utmost importance that cardiac output reference methods are easy 
and safe to apply, as well as accurate and precise.  Otherwise there is a risk that we may 
reject promising, non-invasive monitors, not due to their own flaws, but because of 
imperfections in the reference method. 
Paper V 
It is important that pediatricians understand the limitations of empirical body surface 
area formulas. It seems clear that the Mosteller formula is the simplest and most reliable 
body surface area formula that is available for young children.  However, caution is 
advised regarding normalization of the physiological parameters with body surface area 
in the youngest children.   
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Recommendations regarding 
comparative studies 
• Use larger sample of subjects and carry out power analyses before starting all 
studies 
• Use homogeneous samples of patients   
• Measure the precision of the reference method  
• Carry out repeated measurements 
• Always report bias, SDs, limits of agreement, precision of methods and 
percentage errors 
• Report if there are any missing data 
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Sammanfattning på svenska  
(Swedish summary) 
Befintliga tillförlitliga metoder för att mäta hjärtminutvolymen har bara kunnat 
användas på större barn och vuxna. För att bedöma hemodynamiken hos små barn har 
vi varit hänvisade till indirekta mätningar som blodtryck och centralt ventryck.  En ny 
ultraljudsbaserad utrustning som mäter utspädningen av fysiologisk koksalt i blodet har 
utvecklats för att bland annat bestämma hur mycket blod hjärtat pumpar hos små barn 
(COstatus, Transonic, Ithaca, USA). Tekniken är lämplig att användas på barn 
eftersom den är säker, kräver inte några ytterligare blodprovstagningar och utnyttjar 
befintliga katetrar som alla små barn får i samband med svåra sjukdomstillstånd och 
större operationer.  
Målsättning med detta doktorandarbete var att utvärdera teknikens pålitlighet och dess 
möjlighet att bedöma hemodynamiken på mindre barn.  Data insamlades på barn som 
genomgick korrektiva hjärtoperationer åren 2010-2017 vid Skånes Universitets 
Sjukhuset i Lund.  Förhoppningen  med projektet är att kunna visa att tekniken  kan 
användas för att förbättra diagnostiken och intensivvården hos svårt sjuka barn.  
Doktorandarbetets första och fjärde studie utvärderade metodens precision och 
noggrannhet jämfört med dagens två „gold standard“ metoder, d.v.s. direkt 
flödesmätning på stora kroppspulsådern och direkt Ficks metod.  I andra studien 
utvärderades teknikens förmåga att detektera intrakardiella shunt och bestämma shunt 
fraktionens storlek. I tredje studien bestämde vi om vikt eller kroppsytan var bäst 
lämpad för att indexera, dvs jämföra olika uppmätta hemodynamiska parametrar hos 
små barn vid olika åldrar. I femte studien jämförde vi de mest använda matematiska 
formlerna som används för beräkning av kroppsytan på små barn och som används för 
indexering av de olika hemodynamiska parametrarna. 
Utvärderingen visade att tekniken var  mycket nogrann och hade en hög precision 
jämfört med använda referens metoder för att bestämma hjärtminutvolymen. Tekniken 
var säker, mindre invasiv än tidigare tekniker för att bestämma hjärtminutvolym och 
shuntfraktionens storlek och kunde användas även på de minsta barnen. Enligt vår 
analys visade tekniken en så hög noggrannhet och precision att den kan användas som 
referens vid bestämning av hjärtminutvolymen på små barn. Vikten var bättre än 
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kroppsytan på att indexera de hemodynamiska parametrarna hos barn under 15 kg. 
Samtidigt visade analysen en skillnad i beräknad kroppsyta beroende på vilken 
matematisk formel som användes.  
Betydelsen av vårt arbete är att vi visat att tekniken är pålitlig och tillför flera 
hemodynamiska värden som kan användas för att bedöma barnens cirkulatoriska 
tillstånd under intensivvård och i samband med operativa ingrepp. Tekniken är också 
lämpad på små barn vid utvärdering av läkemedelseffekter på hemodynamiken.  
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Ágrip á íslensku  
(Icelandic summary) 
Mat á óstabílum sjúklingum er ekki eins einfalt og telja mætti.  Fjölmargar rannsóknir 
hafa sýnt fram á að oft er lítið samræmi á klínískum einkennum og mælingum 
lífsmarka.  Ýmis hjálpartæki hafa verið þróuð í gegnum tíðina til að aðstoða við mat á 
blóðrásarástandi sjúklinga.   Ber þar hæst að nefna hinn fræga Swan-Ganz æðalegg 
(þræddur í lungnaslagæð) til að mæla hin ýmsu blóðrásargildi.  Stærð og umgjörð Swan-
Ganz æðaleggsins er þó takmarkandi þáttur hvað varðar börn vegna aukinnar áhættu á 
fylgikvillum við ísetningu (blæðing, æðastífla, æðarof eða hjartsláttartruflanir). 
Tækjabúnaður sem gæti metið ástand hjartans og blóðflæði um líkama barna, myndi 
hjálpa læknum við heildarmat á ástandi alvarlega veikra barna og kæmi að miklu gagni 
við ákvörðun stuðningsmeðferðar.  
Nýlega kom á markaðinn tækið COstatus frá Transonic Systems í Bandaríkjunum sem 
gerir loksins kleyft að meta þessa þætti sem varpa betra ljósi á ástand barna án þess þó 
að krefjast ísetningar á meira ífarandi æðaleggjum en almennt þarf hjá 
gjörgæslusjúklingum (holæða- og slagæðalegg).  Tækið framkvæmir mælingar sínar með 
ómtækni sem nemur blóðflæðisbreytingar í blóðrásinni eftir  innspýtingu á fyrirfram 
ákveðnum magni af saltvatni (byggt á Stewart-Hamilton lögmálinu). 
Tækið gerir gjörgæslulæknum kleyft að greina og meta breytingar á útflæði hjartans, 
viðnámi í æðakerfinu, vökvaástand og hugsanleg op milli hjartahólfa sem oft eru 
ógreind í ungabörnum. 
Markmið þessarar doktorsritgerðar var að meta ýmsa þætti sem snúa að blóðrás ungra 
barna og gera röð samanburðarannsókna með hinu nýja COstatus tæki við eldri 
staðalaðferðir. 
Frá febrúar 2010 til júní 2017 voru framkvæmdar samanburðarmælingar í tæplega 70 
börnum við Barnaspítalann í Lundi sem voru að gangast undir opnar hjartaaðgerðir.  
Niðurstöður rannsókna okkar leiddu í ljós að COstatus tækið var öruggt og áreiðanlegt 
til notkunar í ungum börnum ásamt því að gefa afar nákvæmar niðurstöður í 
samanburði við fyrri aðferðir. 
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Nákvæmni COstatus tækisins var slík að það ætti að geta tekið við sem ný staðalaðferð 
til mats á blóðrásarástandi barna og þannig leysa fyrri ífarandi aðferðir af hólmi. Tækið 
gæti þannig á næstu árum auðveldað mat á alvarlega veikum gjörgæslusjúklingum og 
hugsanlega hraðað framþróun minna ífarandi hjálpartækja á sama sviði í framtíðinni. 
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Aspects of pediatric hemodynamics
Clinical estimation of hemodynamic 
status in children is very challenging.
This thesis explores and compares 
different methods for estimation 
of hemodynamic status in young 
children undergoing heart surgery.
The picture, shows part 
of the Sigurdsson family 
doing hemodynamic estimations.
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